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POP-1, a Tcf/Lef-1-like target of the convergent Wnt and MAP kinase (MAPK) signaling pathways, functions throughout Caenorhabditis
elegans development to generate unequal daughters during asymmetric cell divisions. A particularly prominent such asymmetric division
occurs when the EMS blastomere divides to produce MS, a mesoderm precursor, and E, the sole endoderm progenitor. POP-1 allows
mesoderm development in the MS lineage by repressing the endoderm-promoting end-1 and end-3 genes. This repression is relieved in the E
lineage by Wnt/MAPK signaling, which results in phosphorylation and export of POP-1 from the E nucleus. Here, we report that, in addition
to repressing E development in MS, POP-1 also functions positively in endoderm development, in conjunction with the well-characterized
endoderm-promoting SKN-1YMED regulatory cascade. While removal of POP-1 alone results in derepression of endoderm development in
the MS lineage, mutations in several genes that result in impenetrant loss of endoderm are strongly enhanced by loss of pop-1 function. A
Lef-1-like binding site is essential for activation of an end-1 promoter fusion, suggesting that POP-1 may act directly on end-1. Thus, POP-1
may generate developmental asymmetry during many cell divisions in C. elegans by reiteratively switching from repressive and activating
states. Furthermore, we report that the Caudal-like homeodomain protein PAL-1, whose role in early embryogenesis was thought to be
exclusive specification of mesectodermal development in the lineage of the C blastomere, can act with POP-1 to activate endoderm
specification in the absence of the SKN-1YMED transcriptional input, accounting for the impenetrance of mutants lacking SKN-1 or MED-
1,2 activity. We conclude that the combined action of several separate transcriptional regulatory inputs, including SKN-1, the MEDs, PAL-1,
and the Wnt/MAPK-activated form of POP-1, are responsible for activating end gene transcription and endoderm development.
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The Wnt signaling pathway functions in a large number
of cellular activities in metazoans, including cell type
specification, cell polarization, spindle orientation, control
of cell division, and morphogenesis (Cadigan and Nusse,
1997; Miller and Moon, 1996; Moon et al., 2002; Roose and
Clevers, 1999). In the nematode Caenorhabditis elegans,
the Wnt pathway acts reiteratively throughout development0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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resulting in dissimilar daughters (Eisenmann et al., 1998;
Herman, 2001; Herman and Wu, 2004; Lin et al., 1998;
Maloof et al., 1999). The generation of unequal daughter
cells by Wnt signaling during C. elegans development is
first seen in the four-cell embryo (Fig. 1) (Rocheleau et al.,
1997; Thorpe et al., 1997). At this stage, the posterior-most
blastomere, P2, sends a polarizing inductive signal to its
neighbor, the EMS mesendoderm progenitor. Upon division
of EMS, the side that had received the P2 signal gives rise to
the endoderm progenitor, or E cell; the opposite side, which
received no signal, generates the mesoderm-generating MS
cell (Goldstein, 1992, 1993, 1995; Schierenberg, 1987). The
inductive signals emanating from P2 activate a Wnt path-
way, a MAP kinase (MAPK) signaling cascade, and an Src-85 (2005) 510 – 523
Fig. 1. Canonical Wnt pathway and C. elegans embryonic Wnt pathway.
(A) In the canonical Wnt pathway, Wnt signaling results in activation of a
bipartite transcription factor consisting of h-catenin and a TCF/Lef factor,
which activates target genes (reviewed in Cadigan and Nusse, 1997). In the
absence of the Wnt signal, TCF/Lefs can function as repressors (not shown
on the figure) (Kim et al., 2000; Merrill et al., 2001). A similar pathway is
proposed to exist for postembryonic C. elegans signaling events (Herman,
2001; Herman and Wu, 2004; Korswagen et al., 2000). (B) The Wnt
pathway as previously described for C. elegans E specification. At the 4-
cell stage, P2 polarizes the ventral blastomere EMS (depicted by shading of
the EMS cytoplasm) such that its posterior daughter becomes E. The
terminal TCF/Lef-1-like regulator, POP-1, represses E specification in MS
by preventing activation of end-1,3 by the SKN-1/MED-1,2 pathway
(Calvo et al., 2001; Maduro et al., 2002; Maduro et al., 2001). A newly
hatched L1 animal is diagrammed showing the 20 E nuclei (dots) that
constitute the intestine.
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EMS (Bei et al., 2002; Ishitani et al., 1999; Meneghini et al.,
1999; Rocheleau et al., 1997; Thorpe et al., 1997).
Wnt/MAPK/Src signaling apparently functions in endo-
derm induction by inactivating POP-1, a TCF/LEF-related
repressor of E-specific gene activity. In the MS cell,
unsignaled POP-1 represses endoderm-specific gene acti-
vity, allowing mesoderm development to occur (Lin et al.,
1995; Rocheleau et al., 1997; Thorpe et al., 1997). Several
lines of evidence led to the view that the Wnt/MAPK/Src
signaling functions to abrogate the endoderm-repressing
activity of POP-1 rather than acting positively to direct
endoderm development. First, in the absence of POP-1
activity, both E and MS produce endoderm independent of
Wnt/MAPK/Src signaling (Lin et al., 1995, 1998). Second,
a complex of the h-catenin-like molecule, WRM-1, and an
MAPK component, LIT-1, can phosphorylate POP-1 in
vitro (Rocheleau et al., 1999), and phosphorylation has
been shown to disrupt the DNA-binding properties of other
TCF/Lef factors (Ishitani et al., 2003). Third, nuclear POP-1
levels are reduced in the E cell in response to Wnt/MAPK
signaling as a result of redistribution of the protein to thecytoplasm mediated by the 14-3-3 protein PAR-5 (Ishitani et
al., 1999; Lin et al., 1998; Lo et al., 2004; Maduro et al.,
2002; Meneghini et al., 1999). Similarly, expression of
WRM-1 and LIT-1 results in relocalization of POP-1 from
the nucleus to the cytoplasm in cultured mammalian cells
(Rocheleau et al., 1997).
Induction of endoderm by a double negative pathway
originally suggested that the Wnt pathway functions differ-
ently in C. elegans than in other organisms (Lin et al., 1995,
1998; Rocheleau et al., 1997; Thorpe et al., 1997). More
recently, it has been shown that, in the absence of signaling,
TCF/LEF proteins can function as repressors through their
association with Groucho-like co-repressors (Brantjes et al.,
2001; Cavallo et al., 1998). Indeed, the repression of
endoderm fate in the MS cell appears to involve a similar
complex formed by POP-1, the Groucho-like protein UNC-
37, and the histone deacetylase HDA-1 (Calvo et al., 2001),
showing that the repressive role of non-Wnt signaled POP-1
has been evolutionarily conserved. However, while nuclear
POP-1 levels decrease in response to Wnt/MAPK signaling,
significant levels of POP-1 are nonetheless detected in the E
nucleus (Lin et al., 1995, 1998; Maduro et al., 2002),
suggesting that it may also function in signaled cells.
Indeed, postembryonically, POP-1 associates with the
h-catenin BAR-1 to activate the Wnt target gene mab-5
(Korswagen et al., 2000), and in gonadogenesis, WRM-1
and LIT-1 are required to activate POP-1 function rather
than to abrogate its function (Siegfried and Kimble, 2002).
It therefore remains a possibility that Wnt-signaled POP-1
may also perform an as yet undetected function in endoderm
development.
Endoderm is specified by two redundant, zygotically
expressed GATA-type transcription factors that are suffi-
cient and together essential for endoderm development
(Maduro and Rothman, 2002; Zhu et al., 1997). The end
genes are expressed exclusively in the early E lineage in
response to activation by the zygotically expressed MED-
1,2 proteins, redundant, non-canonical GATA transcription
factors. Expression of the med genes in the E and MS
lineage is initiated by the maternally provided SKN-1
transcription factor, and the SKN-1YMED pathway speci-
fies development of both E and MS (Bowerman et al., 1992;
Maduro et al., 2001; Maduro and Rothman, 2002). While
the SKN-1YMED pathway is absolutely essential for MS
development, ¨30% of embryos lacking SKN-1 and ¨50%
of embryos lacking MED-1,2 generate gut, indicating that
an SKN-1, MED-independent mechanism also specifies
endoderm.
In embryos that do not make endoderm as a result of
defects in the SKN-1YMEDYEND pathway, the E cell
adopts the fate of its cousin, the C blastomere, which gives
rise to mesectoderm (muscle, epidermis, and neurons).
Conversion to a C-like blastomere, as well as the normal
C fate, requires maternal contribution of the Caudal-like
homeodomain protein PAL-1 (Hunter and Kenyon, 1996).
While maternal PAL-1, like SKN-1, is expressed in both the
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endoderm-expressed PAL-1.
We report here that, although the SKN-1YMED cascade
is required for high levels of end-1 expression, end-1 is
expressed at low levels in the absence of SKN-1 or MED-
1,2, consistent with the impenetrance of the endoderm
specification defect in skn-1 and med-1,2 mutants. We
found that Wnt-modified POP-1 is responsible in part for
this SKN-1, MED-independent activation of end-1 and
endoderm development and that a Lef-1-like site is essential
for activation of end-1, consistent with a positive role for
POP-1 in endoderm development. These findings suggest
that POP-1 is converted from a repressor to an activator of
endoderm gene expression. We also made the unexpected
finding that PAL-1 activates endoderm in the E lineage
when the SKN-1YMED pathway is inactive. Thus, the
positive action of POP-1 and PAL-1 on end gene expression
accounts for the impenetrance of mutants lacking SKN-1,
and the SKN-1YMED, Wnt-activated POP-1, and PAL-1
pathways can function independently to activate endoderm
development in C. elegans.Materials and methods
C. elegans strains and genetics
The following strains were used: N2 [wild type], EU1
[skn-1(zu67) IV/nT1[unc-?(n754) let-?(m435)] (IV;V)],
JJ1057 [pop-1(zu189) dpy-5(e61) I /hT1 (I;V); him-
5(e1490) V/hT1 him-5(e1490) V], EU384 [dpy-11(e1180)
mom-2(or42) V/nT1 [let-?(m435)] (IV;V)], EU353 [skn-
1(zu67) IV/nT1[unc-?(n754) let-?(m435)] (IV;V); mom-
2(or42) unc-42(e70) V/nT1], JJ762 [end-3(zu247) V],
JR1798 [pop-1(zu189) dpy-5(e61)/hT1 (I;V); end-3(zu247)
V/hT1 him-5(e1490) V], and MS162 [med-1(ok804) X; dpy-
17(e164) sDf127 unc-32(e189) III; irDp1 (III;f)]. The
ok804 mutation deletes the entire med-1 locus, and the
deficiency sDf127 deletes med-2 (data not shown). The free
duplication irDp1 balances dpy-17 and sDf127 and includes
an integrated array containing unc-32(+), an unc-119::YFP
reporter used to identify animals carrying irDp1, and
additional copies of med-1(+). The deletion ok1448 deletes
the DNA-binding domain of END-3 (data not shown). A
detailed description of MS162 and RB1331 will be
presented elsewhere.
Constructs and transgenic animals
The 5V-deleted promoter constructs were amplified by
PCR from pJZ21, an end-1 minigene reporter containing 1.7
kbp of noncoding 5V DNA fused to an end-1 cDNA
fragment encoding amino acids 1–191 of the 221-aa
END-1 coding region inserted into plasmid pPD96.04
(NLS::GFP::lacZ::unc-54_3VUTR; a gift from A. Fire).
Animals containing 5V-deleted promoter::reporter fusionswere obtained by injecting gel-purified PCR products derived
from pJZ21 as template. The SKN-1 and GATA sites in
construct E265 were substituted by use of an imperfect 3V
oligonucleotide, and deletion of the 165 Lef site was
performed using a PCR-based cloning strategy with the
enzyme EarI; both constructs were cloned into pPD96.04,
the critical regions were sequenced, and then the promo-
ter::reporter segment was amplified by PCR for injection.
Oligonucleotide sequences and cloning details are available
on request. For injections, the marker pRF4 (rol-6D) was
used, and DNA mixtures were injected at a concentration of
10–100 ng/Al. Chromosomal integrants for the constructs
E1720, Er880, and Er880DLef were obtained from an
extrachromosomal line following irradiation at 400 J/m2
using a UV crosslinker (Stratagene) and identification of
integrants in the F2 generation.
RNA interference (RNAi)
dsRNA was synthesized using the MEGAscript kit
(Ambion) from T7 promoter-tagged fragments of cDNA
clones as described (Maduro et al., 2001). For experiments
involving skn-1(RNAi) and pop-1(RNAi), soaking of parent
animals in dsRNA (Timmons and Fire, 1998) was found to
be as effective as direct gonadal injection (Fire et al., 1998).
For soaking experiments, 10 to 50 gravid adult hermaph-
rodites were immersed in 4 Al dsRNA (¨4 Ag/Al) in RNase-
free water for 8–12 h then recovered on seeded plates for
12–15 h prior to embryo collection for phenotype analysis
or X-gal staining. For injection, dsRNA at a concentration
of ¨4 Ag/Al was injected into both gonad arms of 10–20
hermaphrodites, and animals were allowed to recover for
12–15 h. For RNAi soaking or injection experiments
targeted to multiple genes, equimolar mixtures of the
dsRNAs were used. For dsRNA delivery into strain
MS162, animals were fed E. coli HT115 expressing dsRNA
corresponding to a fragment of the pop-1 or pal-1 cDNAs
(Timmons et al., 2001). All experiments were performed at
20-C.
X-gal staining
Ten to 100 adult gravid worms were placed in the lid of
an microfuge tube, and all liquid was removed before
placing on dry ice for a minimum of 10 min. Worms were
then lyophilized for 1 h, then cold ethanol was added,
followed by the slow addition of PBST. Worms were
washed 2, and then 100 Al of X-gal staining solution was
added (Fire, 1992). Stain was developed at 37-C until
visible. Strength of reporter expression was judged based on
both intensity of staining as well as time taken to see signal.
Antibody staining
Staining was performed on methanol–acetone fixed
embryos as described (Zhu et al., 1997). h-galactosidase
M.F. Maduro et al. / Developmental Biology 285 (2005) 510–523 513(lacZ) was detected using a monoclonal h-gal Ab (Promega
#Z3781), and intestine was detected with the monoclonal
Ab MH33 (a gift from R. Waterston). Secondary antibodies
were obtained from Sigma.Table 1
Intestinal differentiation in mutant embryos
Genotype % Intestinea (n)
Wild type 100% (n > 500)
skn-1(zu67) 36% (164)
skn-1(RNAi)b,c 28% (731)
skn-1(RNAi); unc-22(RNAi)b 30% (60)
pop-1(zu189) 96% (45)
pop-1(RNAi)b,c 96% (437)
pop-1(RNAi); unc-22(RNAi)b 95% (100)
pal-1(RNAi)c 100% (235)
pal-1(RNAi); pop-1(RNAi)c 100% (437)
skn-1(zu67); pop-1(zu189) 30% (118)
skn-1(zu67); pop-1(RNAi)b 5% (323)
skn-1(RNAi); pop-1(zu189)b 32% (394)
skn-1(RNAi); pop-1(RNAi)b,c 11% (1245)
skn-1(RNAi); pal-1(RNAi)c 9% (323)
skn-1(RNAi); pop-1(RNAi); pal-1(RNAi)c 0% (519)
med-1(ok804); sDf127d 45% (260)
med-1(ok804); sDf127; pop-1(RNAi)e 6% (95)
med-1(ok804); sDf127; pal-1(RNAi)e 7% (190)
end-3(zu247) 91% (247)
end-3(ok1448) 95% (155)
end-3(zu247); pal-1(RNAi)c 68% (327)
end-3(zu247); pop-1(zu189) 14% (78)
end-3(zu247); pop-1(RNAi)c 3% (175)
end-3(ok1448); pop-1(RNAi)c 1% (262)
end-3(zu247); pop-1(RNAi); Ex[end-3(+)]c 99% (79)
a Scored by presence of birefringent gut granules in terminal embryos.
b Soaking of parent hermaphrodites in dsRNA was used. The proportion
of gutless embryos was found to be comparable to results obtained by direct
injection.
c Direct injection of dsRNA into parent hermaphrodites was used.
d sDf127 deletes med-2 and is linked to recessive mutations in dpy-17
and unc-32.
e Growth of hermaphrodite parents on E. coli HT115 bacteria expressing
dsRNA was used.Results
Endoderm-specific expression of end-1 is regulated by
SKN-1, the MEDs, POP-1, and the Wnt pathway
We sought to characterize the regulatory inputs that
direct the expression of end-1 to the E lineage by examining
expression of an end-1 gene reporter in embryos defective
for genes required for normal endoderm development. A 1.7
kb end-1 sequence upstream of the apparent transcriptional
start site is sufficient to direct robust expression of a lacZ
reporter in the early E lineage, similar to that of the
endogenous RNA revealed by in situ hybridization (Zhu et
al., 1997); however, while transcripts are first detectable in
the E cell, reporter expression is not apparent until after E
has divided, likely owing to the short length of the E cell
cycle and a temporal requirement for transgene product
accumulation. This sequence, coupled to the end-1 coding
region and 3VUTR, is sufficient to restore endoderm
development in transgenic embryos homozygous for a
deficiency that eliminates end-1 and its redundant partner
end-3 and which otherwise never produces endoderm
(Maduro and Rothman, 2002; Zhu et al., 1997).
We first assessed the requirement for the SKN-1YMED
pathway on end-1 expression. We previously found that
depletion of med-1,2 function by RNAi results in reduced
expression of an end-1 reporter (Maduro et al., 2001). To
test the effect of removing the contribution of med-1, med-2,
and skn-1 together, we examined expression of an end-1
reporter in embryos depleted for skn-1; such embryos show
no detectable expression of med-1,2, which are apparent
direct targets of SKN-1 action (Maduro et al., 2001). 49%
(n = 350) of skn-1(RNAi) embryos fail to express the end-1
reporter entirely, while the remainder express it at substan-
tially reduced levels, consistent with the impenetrant lack of
gut in skn-1 mutants (see below). These observations also
suggest that end-1 can activate endoderm development even
when expressed at diminished levels.
A comparison of the requirement for SKN-1 and the
MEDs suggests that SKN-1 provides both MED-dependent
and -independent inputs into end gene transcription. While a
large fraction of both skn-1 and med-1,2 mutant embryos
lack endoderm, ¨30% of skn-1(zu67) mutants and ¨50% of
med-1,2(RNAi) embryos contain a differentiated gut
(Bowerman et al., 1992; Maduro et al., 2001). This
difference in penetrance might be attributable to the lower
efficacy of RNAi compared to a chromosomal mutation or
may reflect a greater requirement for SKN-1 than the MEDs
for endoderm specification. To address these alternatives,
we examined embryos lacking the chromosomal copies ofboth med-1 and -2 by constructing a strain carrying the med-
1(ok804) X deletion identified by the C. elegans Knockout
Consortium and the deficiency sDf127 III, which removes
many genes including med-2 (data not shown). Consistent
with our observations of med-1,2(RNAi) embryos, we found
that 45% (n = 260) of med-1(ok804); sDf127 embryos,
which appear to lack all MED activity, make endoderm
(Table 1). These findings suggest that some SKN-1 may be
independent of the MEDs; for example, it may act directly
on the end genes, consistent with the presence of SKN-1
sites in these genes (see below; Zhu et al., 1997).
We next examined the effect of eliminating the endo-
derm-inducing Wnt pathway on end-1 expression. We
found that the end-1 reporter is often expressed in embryos
lacking maternal MOM-2, the Wnt-like molecule apparently
produced by P2 that induces endoderm in EMS (Rocheleau
et al., 1997; Thorpe et al., 1997). As with the skn-1 mutants,
the fraction of embryos expressing end-1 is greater than the
fraction that produces endoderm: in the mom-2(or42)
mutant, ¨28% of the embryos contain a gut (Thorpe et
al., 1997), yet ¨50% express the end-1 reporter, albeit at a
reduced level (Fig. 2E). Embryos lacking both MOM-2 and
SKN-1 virtually never contain a gut (Thorpe et al., 1997),
Fig. 2. Expression of end-1 in maternal mutants. Confocal micrographs of fixed embryos show expression of a full-length promoter end-1::NLS::GFP::lacZ
transgene in wild-type (A–C) and mutant (D–G) backgrounds, as detected by staining for immunoreactive h-galactosidase. (A) Strong expression in the two E
daughters at the 28-cell stage. Weak expression of the reporter is detectable in the four MS descendants. (B) 4E (¨64-cell) stage. (C) 8E (¨128-cell) stage. (D)
Reduced end-1 expression was observed in 51% (n = 350) of skn-1(RNAi) embryos as shown here at the 2E stage. (E) 50% (n = 86) of mom-2(or42) mutant
embryos express end-1 as shown for the 2E stage. Because gastrulation fails in these mutants, the endoderm cells remain at the ventral–posterior surface of the
embryo. (F) 19% (n = 27) of skn-1(zu67); mom-2(or42) embryos display some end-1 expression (shown at the 4E stage). (G) Derepression of end-1 in the MS
lineage is observed in 100% (n = 138) of pop-1(RNAi) embryos. The embryos shown in panels (F) and (G) carry an extrachromosomal end-1::NLS::GFP::lacZ
array, while the remaining embryos carry the chromosomal end-1::NLS::GFP::lacZ insertion wIs28. The percentage of expressing embryos given above has
been adjusted for transmission frequency of the array in panels (F) and (G).
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parallel to activate endoderm development. We found that
¨19% of skn-1(zu67); mom-2 (or42) embryos express the
end-1 reporter (Fig. 2F). Thus, the Wnt pathway and SKN-1
collaborate to activate end-1 expression; however, the
residual expression in the double mutant suggests that there
is yet another factor that activates end-1 (see below).
Maternal POP-1, which represses endoderm differentia-
tion in the MS lineage, is the target of the endoderm-
inducing Wnt signal. We found that elimination of maternal
POP-1 by either a chromosomal pop-1 mutation or by RNAi
results in expression of the end-1 reporter in descendants of
both the E and MS blastomeres (Fig. 2G), supporting the
view that the major role of POP-1 in endoderm specification
is as a repressor of end-1 (and end-3) in MS (Calvo et al.,
2001; Maduro et al., 2002).
Potential conserved regulatory elements in end-1 include
consensus binding sites for SKN-1, POP-1, and GATA
factors
The foregoing studies establish that end-1 transcription is
regulated by the SKN-1YMED pathway and POP-1.
Immunoreactive SKN-1 and POP-1 are both found in the
nucleus of the E blastomere (Bowerman et al., 1993; Lin et
al., 1995), as are GFP- or myc-tagged versions of MED-1
(Maduro et al., 2001). MED-1 binds to two sites in the end-
1 promoter both in vitro and in vivo (Broitman-Maduro etal., 2005; Maduro et al., 2002). To assess the potential of
POP-1, SKN-1, and END-1/3 to interact directly with the
end-1 promoter, we examined the regulatory regions of end-
1, end-3, and homologs of end-1 and end-3 in the related
species C. briggsae (Fig. 3) (Maduro et al., in press; Zhu et
al., 1997). C. briggsae is estimated to have diverged from C.
elegans ¨50–120 Myr ago, and comparisons of noncoding
regions between these species can be used to establish sites
important for regulation (Coghlan and Wolfe, 2002;
Kennedy et al., 1993). A number of sequences correspond-
ing to consensus recognition sites for known transcription
factors are apparent in the regulatory regions of all four end
genes. Consensus binding sites for SKN-1 (RTCAT)
(Blackwell et al., 1994), GATA factors (HGATAR) (Lowry
and Atchley, 2000), and the newly identified MED-1
binding site (RAGTATAC) (Broitman-Maduro et al.,
2005) are present at several positions, often in close
proximity (Fig. 3). Within C. elegans end-1, for example,
a cluster of five SKN-1 sites extends from 570 to 1000
bp, suggesting that this region might act as a SKN-1-
responsive module. In addition, two sequences that match
the consensus binding site for the mammalian homolog of
POP-1, Tcf/Lef-1 (CTTTGWW) (Lin et al., 1995; Travis et
al., 1991) are present in end-1; we will refer to these as Lef-
1 sites. Ce-end-1, Ce-end-3, and Cb-end-1 all contain at
least one Lef-1 site within the proximal-most 200 bp. As
POP-1 can bind to Lef-1 sites (Korswagen et al., 2000),
these are excellent candidates for sites of direct POP-1
Fig. 3. Putative regulatory sites in the upstream sequences of the end genes of C. elegans and C. briggsae. Sites are denoted by symbols above each promoter
(thick line) if they reside on the top strand and below if they reside on the bottom strand. A legend for the symbols used, and the corresponding consensus
sequence, is shown at the bottom of the figure. Based on 5VRACE analysis, the 5Vends of the end-1 and end-3 transcripts are within <5 bp of their respective
translation start sites (Maduro et al., in press; Zhu et al., 1997). For consistency, coordinates are given relative to translation start sites (arrows). In C. briggsae,
there are two end-3 homologs expressed as divergent transcripts from an intervening 3024 bp promoter. All five end genes show E lineage-specific expression
in C. elegans (Maduro et al., in press; Zhu et al., 1997).
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regulatory regions, we conclude that the end genes in C.
elegans and C. briggsae may be directly controlled by the
regulatory inputs described above, including POP-1.
Requirement for a Lef-1 site in end-1 activation
As there are numerous putative transcription factor bind-
ing sites in end-1, we sought to simplify the analysis of the
promoter by identifying aminimal region capable of directing
E lineage-specific expression of end-1. A series of 5V
deletions was created in the end-1::lacZ reporter and trans-
genic embryos assayed for h-galactosidase expression.
Sequential removal of distal promoter segments revealed
that each contributes incremental activating functions; how-
ever, none of these is essential for proper spatial and temporal
regulation of end-1 in the E lineage (Fig. 4 and data not
shown). Removal of a cluster of SKN-1 sites between 570
and 1000 bp results in greatly reduced reporter expression
levels, consistent with the aforementioned genetic data
suggesting that SKN-1 provides MED-independent endo-
derm specifying activity. Furthermore, comparison of dele-
tion constructs differing in retention of a single GATA site at
414 bp (E1000 vs. Er880 and E487 vs. E402) reveals that
this site contributes positively to end-1 activation. While
MED-1 does not bind to a canonical GATA site (Broitman-Maduro et al., 2005), the contribution of this site to end-1
activation implicates autoregulation by END-1 or activation
by END-3. Recombinant END-1 protein can bind a canonical
GATA site, suggesting that END-1 recognizes a GATA site in
C. elegans (Shoichet et al., 2000).
These analyses demonstrated that the proximal-most 310
bp of the end-1 promoter (construct E310) is sufficient for
expression of the reporter specifically in the E lineage.
Further removal of an additional 95 bp results in sporadic
ectopic expression outside of the E and MS lineages later in
embryogenesis. However, this minimal 215 bp construct
contains all elements sufficient for activation of some end-1
expression in the E lineage, as well as repression in the MS
lineage, as it does not show increased expression in MS
above the trace amount detected with the full-length
promoter (not shown).
The consensus binding sites in the minimal 215 bp
segment include Lef-1, SKN-1, MED-1, and GATA sites
(Fig. 4). We predicted that POP-1 might repress end-1 by
acting through this Lef-1 site; in such an event, removal of
the site would be expected to cause a pop-1()-like
phenotype, resulting in expression in both the E and MS
lineages. To our surprise, either upstream deletion (E158) or
precise removal (E310DLef) of the Lef-1 site abolished
expression of the end-1 reporter. This result indicates that
the Lef-1 site may also be required for activation, in addition
Fig. 4. Identification of a minimal end-1 promoter and requirement for candidate cis-acting sites. Fragments of the 1.7-kbp end-1 promoter that were cloned
into the vector pPD96.04 are shown alongside the construct name (i.e. FE1720_ for the full-length promoter) and a representation of end-1 reporter levels, based
on the X-gal staining of fixed embryos. , +, ++, +++, and ++++ denote successive levels of signal (++++, strongest signal; +, weak signal; , no signal
detectable). Putative transcription factor binding sites are shown as in Fig. 3.
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POP-1, it would contrast with the prevailing view that POP-
1 function as a repressor of endoderm is merely down-
regulated in E and hence lacks a function when modified by
Wnt/MAPK signaling.
POP-1 acts synergistically with SKN-1 to activate end-1
expression and endoderm development
The finding that an Lef-1 site is essential for end-1
expression led us to consider the possibility that POP-1,which binds to Lef-1 target sequences (Korswagen et al.,
2000), may function as an activator of end-1 in the E cell.
This activating function could account for the ability of
embryos to make endoderm in the absence of SKN-1 or the
MEDs (Bowerman et al., 1992; Maduro et al., 2001). Such
an activating role for POP-1 would likely have eluded
detection in pop-1 mutants owing to robust activation of end-
1 by SKN-1 and MED-1,2. In a mutant lacking maternal
pop-1 function, MS-specific repression is eliminated and
SKN-1 and MED-1,2 can activate end-1 in both cells (Fig.
2G), thereby masking the requirement for a positive role for
Fig. 6. Synergistic effect of SKN-1 and POP-1 on end-1 expression levels.
end-1::NLS::GFP::lacZ expression was revealed by X-gal staining of 64-
cell stage embryos in utero. (A) Wild-type. (B) pop-1(RNAi) showing
ectopic expression in both MS (smaller nuclei) and E descendants (larger
nuclei). (C) skn-1(RNAi). (D) pop-1(RNAi); skn-1(RNAi). The signal in the
double mutant is much weaker than in skn-1(RNAi) alone. The wild-type
embryo in panel (A) has been stained for a longer period of time than in
panels (B–D).
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therefore be evident only when SKN-1 is absent.
We found that simultaneous depletion of SKN-1 and
POP-1 by RNAi reveals a requirement for POP-1 in
activation of end-1. While 88% of POP-1-depleted and
51% of SKN-1-depleted embryos express the end-1
reporter, only 21% of embryos depleted for both SKN-1
and POP-1 expressed the reporter (Fig. 5). The decrease in
the fraction of embryos expressing the reporter was highly
significant (P < 0.00001 for skn-1 vs. skn-1; pop-1
mutants). This synergistic effect of removing both POP-1
and SKN-1 was reflected not only in the fraction of embryos
expressing the reporter, but also in the expression levels
observed: skn-1(RNAi); pop-1(RNAi) embryos express the
reporter at substantially lower levels than embryos depleted
for the function of either gene alone (Fig. 6). Together, these
findings demonstrate that POP-1 contributes positively to
end-1 expression in the E lineage.
We next determined whether the decrease in end-1
reporter expression in pop-1(); skn-1() double mutants
compared to skn-1() mutants alone is reflected as a
decrease in the proportion of embryos producing endoderm.
We scored for production of differentiated gut by gut
granule birefringence, expression of an intestine-specific
marker (elt-2::GFP) (Fukushige et al., 1998), and presence
of an intestine-specific antigen detected with the antibody
(Bossinger et al., 2004) in terminally differentiated embryos.
In all three cases, pop-1(RNAi); skn-1(RNAi) mutants
showed a highly significant (P < 0.0003), 2- to 3-fold
decrease in the number of embryos producing gut compared
to skn-1(RNAi) single mutants, while controls with unc-
22(RNAi); skn-1(RNAi) did not result in such a decrease.
The proportion of skn-1(RNAi); pop-1(RNAi) embryos that
produce differentiated gut was less than the fraction
expressing the end-1 reporter, similar to the results obtained
with skn-1 and mom-2 mutant embryos.Fig. 5. Loss of skn-1 and pop-1 function leads to a synergistic defect in endoderm
skn-1() are shown for single and double mutant embryos generated by RNAi.
terminally arrested embryos (MH33, elt-2::GFP, gut granules) positive for each res
the number of embryos scored is indicated at the base of each bar.It was previously reported that a skn-1(zu67); pop-
1(zu189) double chromosomal mutant showed a phenotype
that was indistinguishable from that of the single skn-
1(zu67) mutant alone (Lin et al., 1995), revealing no
interaction between the two mutations. This conflicting
result might indicate that the double RNAi phenotype does
not accurately reflect the simple loss of both gene functions
or alternatively that one of the chromosomal mutations
insufficiently debilitates the corresponding gene to reveal
the synergistic requirement for both SKN-1 and POP-1. To
resolve these conflicting observations, we compared chro-
mosomal double mutant embryos with embryos mutant for
one of the chromosomal mutations and depleted for the
other gene function by RNAi (Table 1). Consistent with the
findings of Lin et al. (1995), the fraction of embryos
lacking gut, ¨30%, was similar in skn-1(zu67) and skn-
1(zu67); pop-1(zu189) double mutants and was also similar
to that in skn-1(RNAi); pop-1(zu189) double mutants.development. Expression of end-1 and intestine production in pop-1() and
Bars show percentage of 28- to 128-cell stage embryos (end-1::lacZ) or
pective marker. The RNAi phenotypes are shown on or above the bars, and
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1(RNAi) embryos produced gut, implying that RNAi
targeted to pop-1 is more effective at eliminating pop-1
function than is the zu189 mutation. The zu189 lesion is a
transposon insertion in the 3VUTR of the gene, specifically
affecting maternal expression of POP-1 (Lin et al., 1995,
1998), suggesting that there may be residual POP-1 activity
in zu189 embryos. The difference we observed accounts for
why the synergistic requirement for POP-1 and SKN-1 in
specification of the endoderm is apparent with pop-
1(RNAi), but not pop-1(zu189). We also found that, when
skn-1 and pop-1 are inactivated by RNAi simultaneously,
11% (n = 1245) of embryos make endoderm. As the skn-
1(zu67) lesion is a nonsense mutation (Bowerman et al.,
1993), the reduced penetrance of skn-1(RNAi); pop-
1(RNAi) (11%) over skn-1(zu67); pop-1(RNAi) (5%) may
reflect the limited efficacy of targeting two genes by RNAi
simultaneously.
Synergy of the endoderm-promoting function of POP-1 with
other genes that act in endoderm development
To examine whether the positive requirement for POP-1
in endoderm development is specifically seen only when
SKN-1 function is reduced, we tested the ability of pop-1
mutants to synergize with other mutants in which end
activity is reduced. The zu247 mutation alters a residue in
the zinc finger of END-3, the redundant partner of END-1
(Maduro and Rothman, 2002), and appears to be hypo-
morphic (Maduro et al., in press), while the ok1448 lesion
deletes the END-3 DNA-binding domain and is predicted to
be a molecular null (our unpublished observations). We
found that, while 91% (n = 247) of end-3(zu247) mutants
made intestine, only 14% (n = 78) of end-3(zu247); pop-
1(zu189) animals and 3% (n = 175) of pop-1(RNAi); end-
3(zu247) animals did (Table 1). Similar results were
obtained with the end-3 molecular null (Table 1): only 1%
of pop-1(RNAi); end-3(ok1448) double mutants made
endoderm. Thus, elimination of pop-1 function is highly
synergistic with reduced end-3 function, which otherwise
results in a very mild phenotype.
We also found that loss of pop-1 function strongly
synergizes with absence of zygotic MED activity: while
45% (n = 260) of med-1(ok804); sDf127 embryos make
endoderm, only 6% (n = 95) of med-1(ok804); sDf127;
pop-1(RNAi) embryos do. Together, these results confirm
the positive contribution of POP-1 in endoderm specifica-
tion and show that the activating function of POP-1 is
apparent even in the presence of functional SKN-1 (see
Discussion).
A Lef-1 site is required for POP-1-dependent end-1 reporter
expression
Given the requirement for both an Lef-1-like site and an
Lef-1-like protein, POP-1, in end-1 activation, it seemslikely that Wnt-activated POP-1 may promote end-1
expression by directly interacting with the end-1 promoter.
While we have previously shown that GFP-tagged POP-1
can form subnuclear Fspots_ in vivo by binding to
extrachromosomal arrays containing the end-1 or end-3
promoters in the MS lineage (Maduro et al., 2002), we do
not know if POP-1 can also act directly on end-1,3
promoters in the E lineage, where it is present at a lower
concentration. To assess the requirement for POP-1 and the
Lef-1 site in end-1 reporter expression, we attempted to
identify the smallest segment of the end-1 promoter that
might reveal a requirement for both POP-1 function (in the
absence of SKN-1) and the 165 Lef-1 site. A small
promoter segment consisting of 310 bp of upstream DNA,
either in isolation (E310) or combined with additional
upstream sequences (Er880), drives E lineage expression
dependent on the SKN-1YMED pathway and the 165
Lef-1 site (Fig. 7). The most informative construct, E1031,
retains sufficient residual expression in skn-1(RNAi)
mutants that the positive contribution of POP-1 can be
measured: while 18% (n = 201) of skn-1(RNAi) embryos
express a reporter derived from E1031, 0% (n = 114) of
skn-1(RNAi); pop-1(RNAi) embryos express this construct,
demonstrating the POP-1 dependence of transcription from
this construct. In contrast, E lineage-specific expression of
a reporter carrying a deletion of the 165 Lef-1 site
(E1031DLef) depends almost exclusively on SKN-1: only
4% (n = 120; P < 0.0002) of skn-1(RNAi) embryos
express this reporter. Hence, the 165 Lef-1 site is
important for the positive contribution of POP-1, support-
ing a direct interaction of Wnt-signaled POP-1 with this
site.
Activation of endoderm by the mesectodermal-specifying
PAL-1 homeodomain protein
Simultaneous removal of SKN-1 and POP-1 function
greatly attenuates but does not abolish, endoderm devel-
opment, suggesting that at least one additional factor can
contribute to endoderm specification. One candidate for
such a factor is Caudal/PAL-1, which is present in all
descendants of P1, including the E cell (Hunter and
Kenyon, 1996). However, PAL-1 is required to specify
the fates of C and D, somatic founder cell descendants of
P2, and pal-1 mutants show no conspicuous defect in
endoderm specification (Hunter and Kenyon, 1996). In
embryos that fail to make endoderm as a result of a
defect in the SKN-1YMEDYEND pathway, the E cell
adopts a C-like fate, producing body wall muscle and
hypodermis (Bowerman et al., 1992; Maduro et al.,
2001); this mesectodermal C-like fate, as with that of the
normal C cell, requires PAL-1, demonstrating that PAL-1
is functional in the E cell (Hunter and Kenyon, 1996;
Maduro et al., 2001). To test whether PAL-1 contributes
to endoderm specification in the absence of SKN-1 and
POP-1, we depleted all three activities by RNAi.
Fig. 7. Expression of end-1 promoter variants in skn-1 and pop-1 mutants. The 165 Lef-1 site accounts for most of the positive POP-1-dependent input into
end-1 expression. Strains bearing different end-1 reporters were tested for E lineage expression dependence on SKN-1 and/or POP-1 activity. Constructs
E1720, E1121, and E1031 show a reduction in expression in pop-1(RNAi); skn-1(RNAi) compared to skn-1(RNAi) alone. In construct E1031DLef, in which the
165 Lef-1 site has been deleted, expression is almost completely dependent upon SKN-1 alone, implicating a requirement for the Lef-1 site in activation by
POP-1. An asterisk (*) indicates data for an extrachromosomal reporter transgene in which the proportion of untreated embryos that express the reporter was
normalized to 100%. The remaining reporters (E1720, Er880, and Er880DLef) were analyzed as integrated arrays.
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was completely abrogated in this triple mutant (n =
519; Table 1), revealing a positive role for PAL-1 in E
specification.
We further tested the effect of depleting pal-1 function in
conjunction with skn-1(RNAi) alone, the double mutant
strain lacking zygotic med-1 and -2, and the end-3(zu247)
mutant. These experiments revealed that PAL-1 function is
required for much of the residual endoderm made in each of
these mutants (Table 1). As with POP-1, this requirement for
PAL-1 in endoderm specification is normally masked by the
SKN-1YMED pathway, and depletion of either pal-1 and
pop-1 function alone, or simultaneous removal of both, fails
to result in an endoderm specification defect. These results
lead to the surprising conclusion that, while PAL-1 is
normally required for the development of the mesectoder-
mal progenitor, C, it can also activate endoderm develop-
ment in the E lineage and that SKN-1, MED-1,2, POP-1,
and PAL-1 can all contribute to endoderm specification in
C. elegans.Discussion
We have shown here that the end-1 gene and endoderm
specification are regulated by several independent transcrip-
tional inputs, including SKN-1YMED, POP-1, acting both
positively (in E) and as a repressor (in MS), and PAL-1,
which normally functions to regulate mesectodermal deve-
lopment in the P2 lineage. Collectively, these findings reveal
that a complex transcriptional network is required to
establish a relatively simple pattern of expression: activation
of end-1 (and, presumably end-3) in a simple clonal lineage
descending from the E cell.
Dual action of POP-1 in both negative and positive
regulation of endoderm
The terminal Wnt pathway regulator POP-1 establishes
transcriptional differences between sister cells throughout
C. elegans development (Herman, 2001; Jiang and Stern-
berg, 1999; Korswagen et al., 2000; Lin et al., 1995, 1998).
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the MS cell different from its sister, E, the endoderm
progenitor (Lin et al., 1995). The role of POP-1 in this
asymmetry was thought to be exclusively as a repressor in
MS, where non-Wnt-signaled POP-1 blocks activation of
the endoderm specification genes end-1 and end-3 by the
SKN-1YMED pathway (Calvo et al., 2001; Maduro et al.,
2002). Although POP-1 is detectable in both the MS and E
cells, it does not appear to be required for endoderm
specification per se (Calvo et al., 2001; Lin et al., 1995;
Maduro et al., 2002). However, we now report several lines
of evidence for an activating role of POP-1 in endoderm
development. First, expression of a minimal end-1 reporter
is dependent on POP-1 and a presumptive POP-1 binding
site for expression. Second, in mutant backgrounds that
reduce expression or activity of the end genes, POP-1 is
required for endoderm specification: in skn-1(zu67), skn-
1(RNAi), med-1,2(), end-3(zu247), and end-3(ok1448)
mutant backgrounds, depletion of POP-1 activity results in
a profound decrease in the levels of end-1 expression and
in the proportion of embryos producing endoderm. In the
most extreme case, loss of POP-1 leads to the nearly
complete (1%) elimination of endoderm in a mutant (end-
3(ok1448)) that otherwise makes endoderm in >90% of
embryos. This latter finding shows that the positive action
of POP-1 in endoderm development is not only required
when the SKN-1YMED pathway is inactivated, but also
likely functions to elevate end gene expression in the E
lineage of normal embryos. We conclude that POP-1 acts
dually as a repressor and an activator of end gene
expression, likely by directly interacting with end regu-
latory sequences.
The original analysis of pop-1 (Lin et al., 1998) did not
reveal its positive contribution to end gene expression and
endoderm development for two reasons. First, the parallel
robust contribution of the SKN-1YMED pathway to end-
1,3 activation masks the positive input of POP-1 in pop-1
mutants. Second, depletion of pop-1 function by RNAi is
more effective at eliminating POP-1 function than is the
maternal-specific mutant zu189; hence, the first experi-
ments investigating the phenotype of the pop-1; skn-1
double mutants did not reveal the synergy of the two
genes.
Our findings explain the observation that, although skn-
1 and med-1,2 mutant embryos invariably fail to produce
MS-derived tissues, a substantial fraction still produce
endoderm (Bowerman et al., 1992; Maduro et al., 2001):
Wnt-activated POP-1 stimulates end-1 expression even in
the absence of the SKN-1YMED pathway. By genetic
criteria, the parallel regulatory inputs of these two path-
ways are redundant; however, they act by quite distinct
mechanisms. Moreover, we have shown that the homeo-
domain protein PAL-1 can promote endoderm development
in parallel with SKN-1YMED and POP-1, accounting for
the small fraction of skn-1; pop-1 mutant embryos that still
produce endoderm.Wnt-signaled and Wnt-unsignaled POP-1 may function at
distinct regulatory sites
While we were able to identify a putative POP-1 site that
is required for positive regulation of an end-1 reporter, we
have been unable to identify a regulatory element that is
required for repression in the MS lineage. Of particular
significance, the 165 Lef-1 site is essential for E-specific
activation of end-1 but is not required for repression in the
MS lineage: construct Er880DLef, in which this site is
deleted, gives E lineage-specific expression, albeit at a low
frequency. If POP-1 represses end-1 by acting exclusively
through this Lef-1 site, then we would expect to observe
expression in both the E and MS lineages. Evidence has
been obtained for a POP-1 repressive complex that includes
the histone deacetylase HDA-1 and the Groucho-like co-
repressor UNC-37 (Calvo et al., 2001). Derepression of an
end-1 reporter is observed in the MS lineage in embryos
depleted for HDA-1; this effect is enhanced when UNC-37
is simultaneously depleted. One possibility, therefore, is that
the SKN-1YMED pathway cannot activate end-1 when
POP-1 is present in this repressive complex. We have
previously shown that GFP-tagged forms of MED-1 and
POP-1 localize to the end-1 promoter in the MS cell,
suggesting that the repressive function of POP-1 does not
preclude simultaneous binding by MED-1 (Maduro et al.,
2002). We postulate that low affinity sites distributed
throughout the end-1 promoter might account for local-
ization of the repressive POP-1 complex; such a possibility
would explain why end-1 promoter sub-fragments do not
show significant derepression.
How does POP-1 function as an activator in the E cell?
TCF/LEF transcription factors are known to activate
transcription only when bound to a h-catenin-like protein
(Cadigan and Nusse, 1997). The C. elegans genome
encodes three recognizable h-catenins, WRM-1, HMP-2,
and BAR-1 (Korswagen et al., 2000; Natarajan et al., 2001),
and a fourth protein, SYS-1, that appears to carry out a
similar function (Kidd et al., 2005). HMP-2 appears to
function in cell adhesion as it is the only C. elegans h-
catenin that interacts with the cadherin HMR-1 (Costa et al.,
1998; Korswagen et al., 2000; Natarajan et al., 2001). While
POP-1 does not activate transcription of a Tcf target reporter
gene in tissue culture, co-expression of POP-1 with SYS-1,
BAR-1, or Drosophila Armadillo, but not WRM-1 or HMP-
2, does result in activation (Kidd et al., 2005; Korswagen et
al., 2000). Of the four h-catenins, BAR-1 and SYS-1 have
been shown to interact directly with POP-1 (Kidd et al.,
2005; Korswagen et al., 2000; Natarajan et al., 2001);
indeed, a BAR-1/POP-1 complex activates postembryonic
expression of the Wnt target gene mab-5, and a SYS-1/
POP-1 complex is proposed to activate Wnt-dependent
genes required for asymmetrical cell divisions in the somatic
gonad (Kidd et al., 2005). Loss of bar-1 function does not
Fig. 8. Revised model for C. elegans endoderm specification. In the
absence of a Wnt signal, an EMS daughter will produce an MS like fate
since unsignaled POP-1 blocks activation of the endoderm-specifying genes
end-1,3 by the SKN-1YMED cascade. The E fate is specified when an
overlapping Wnt/MAPK signal modifies POP-1, resulting in its conversion
into an activator of endoderm. The combination of SKN-1YMED, PAL-1,
and Wnt/MAPK-modified POP-1 results in activation of end-1,3 and
specification of an endodermal fate.
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enhance skn-1() gutlessness (data not shown), suggesting
that POP-1 associates with another h-catenin or that BAR-1
and another h-catenin function redundantly. One possibility
is that WRM-1 is the h-catenin that functions with POP-1.
WRM-1 possesses an activation domain and demonstrates a
weak but detectable interaction with POP-1 in a yeast two-
hybrid assay (Natarajan et al., 2001); moreover, when
expressed under control of the bar-1 promoter, WRM can
substitute for BAR-1 in C. elegans (Natarajan et al., 2001).
In gonadogenesis, depletion of WRM-1 and the Nemo-like
kinase LIT-1 results in the same lineage defects as zygotic
pop-1 mutants, suggesting that WRM-1 and LIT-1 can
contribute to a positive function for POP-1 (Siegfried and
Kimble, 2002). In the early embryo, however, WRM-1/LIT-
1 activity is required to block the repressive function of
POP-1 (Lo et al., 2004; Rocheleau et al., 1999). It is
therefore not possible to detect the positive contribution of
WRM-1 to end-1 activation, as depletion of wrm-1 or lit-1
activity results in the complete absence of endoderm
(Rocheleau et al., 1997; Thorpe et al., 1997). It may be
possible, therefore, that WRM-1 fulfils the requirement of
the h-catenin–TCF interaction involved in transcriptional
activation, as seen in other systems.
A better candidate for the POP-1 coactivator in endoderm
specification is the novel Wnt coactivator SYS-1 (Kidd et
al., 2005). A predicted null mutant of sys-1, q736, shows an
embryonic lethal phenotype, suggesting that SYS-1 does
function in the embryo (Kidd et al., 2005). However, it is
not known when putative zygotic sys-1 activity begins nor
is it known how sys-1 may function maternally as weaker
sys-1 mutants are sterile (Miskowski et al., 2001). As we
have shown that positive POP-1 activity is detectable only
when endoderm specification has been partially compro-
mised, a role for SYS-1 in endoderm specification may yet
be revealed. Therefore, while the mechanism remains to be
elucidated, our findings nonetheless implicate a previously
unrecognized mechanism for embryonic POP-1 activation in
the C. elegans embryo.
A mesectodermal regulatory factor can promote endoderm
development
Our experiments also establish an unexpected role for the
Caudal-like transcription factor PAL-1 in endoderm devel-
opment. PAL-1 is normally required for specification of
mesectoderm in the P2 lineage, and pal-1 mutants show no
discernible endoderm phenotype (Hunter and Kenyon,
1996). Why, then, is PAL-1 required for the residual
endoderm made in skn-1; pop-1 mutants (see Table 1)?
One possible explanation for this finding is that PAL-1 may
bind to the end genes as a means of keeping them repressed
in the C lineage; in so doing, it would ensure that SKN-1,
which is also present in the C lineage, does not activate the
end genes inappropriately. Such a mechanism would be part
of the system used to ensure exclusivity of cell fateassignments to early blastomeres (e.g., Cowan and McIn-
tosh, 1985): a cell in which PAL-1 is active and promotes
mesectoderm development is strongly repressed for other
pathways of differentiation, including endoderm, thereby
ensuring adoption of an exclusive cell fate. GSK-3h, which
prevents SKN-1 from activating the meds in the C lineage
(Maduro et al., 2001), thus allowing PAL-1-dependent
mesectoderm development, may poise this PAL-1/end
interaction toward repression. In the E cell, in which
GSK-3h is apparently not active in blocking the SKN-
1YMED pathway, PAL-1 may lose its end-repressive
activity, allowing PAL-1 bound to the end promoters to
activate rather than repress endoderm development.
A revised model for C. elegans endoderm specification
Our results suggest a revised view of endoderm
specification (Fig. 8), in which POP-1, in response to Wnt
signaling, is converted from a repressor to an activator of the
endoderm-promoting end genes. This POP-1-dependent
activating function is not essential for endoderm formation
since the comparatively stronger contribution by the SKN-
1YMED cascade is unaltered by Wnt signaling in the E
cell. In parallel with these factors, Caudal/PAL-1 also
contributes to endoderm specification. We propose that the
use of POP-1 as both an activator and repressor may occur
recursively throughout embryonic development to establish
differences between daughter cells arising from anterior–
posterior asymmetric cell division.Acknowledgments
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